Today, the VP GM CET of Conmed (CNMD), John Jed Kennedy, sold shares of CNMD for $670.6K.
See today’s analyst top recommended stocks >>
Based on Conmed’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $231 million and quarterly net profit of $6.97 million. In comparison, last year the company earned revenue of $201 million and had a net profit of $5.83 million. The company has a one-year high of $116.81 and a one-year low of $56.91. CNMD’s market cap is $3.18B and the company has a P/E ratio of 111.62.
The insider sentiment on Conmed has been negative according to 61 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific.
